denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: What Are the Advances in Myeloproliferative Neoplasms Affecting Management?
Hematology Disease Topics & Pathways:
Biological therapies, Clinical Practice (Health Services and Quality), Therapies, Transplantation
Session: What Are the Advances in Myeloproliferative Neoplasms Affecting Management?
Hematology Disease Topics & Pathways:
Biological therapies, Clinical Practice (Health Services and Quality), Therapies, Transplantation
Sunday, December 10, 2023, 9:30 AM-10:45 AM
Disclosures: Palmer: Jubliant: Consultancy; Incyte: Consultancy, Other: Money went to the institution; morphosys: Consultancy, Other: Money went to institution; Sierra Oncology: Consultancy, Other: Money went to Institution; CTI BioPharma Corp.: Consultancy, Honoraria, Other: Money went to institution.
See more of: What Are the Advances in Myeloproliferative Neoplasms Affecting Management?
See more of: Education Program
See more of: Education Program
<< Previous Presentation
|
Next Presentation